As five nominees to fill posts at the Federal Trade Commission are awaiting confirmation and its second-to-last sitting commissioner is set to depart, the immediate future of the agency is somewhat uncertain. But the background and makeup of the incoming commissioner class hold clues about what to expect from the commission moving forward.
In a long-running antitrust battle between rival microprocessor companies, Intel Corp. has asked a federal court to force Advance Micro Devices to turn over the details of a study that claims $60 billion of Intel's profits over the past decade came from anti-competitive conduct.
The defendants in a class action over anti-competitive conduct in the insurance industry on Friday insisted that, despite arguments from several plaintiffs, not staying the case as it goes through the appeals court would cause the multidistrict litigation to “degenerate into piecemeal litigation of common issue.”
Madison Square Garden LP has lost the first round of its lawsuit against the National Hockey League when a district court judge declined to issue a preliminary injunction on the league's plans to collectivize all team Web sites.
Medco Health Solutions Inc. and Merck & Co. Inc. have accused pharmacies of distorting a recent Illinois district court decision, allegedly misinterpreting it as affirmation that agreements between buyers to depress prices paid to pharmacies constitute per se anti-competitive price-fixing.
Celgene Corp. is asking a New Jersey court to put the antitrust and unfair competition counterclaims Barr Laboratories Inc. lodged in response to Celgene's patent infringement complaint over the cancer drug Thalomid on the back burner, arguing that letting the counterclaims go forward now would waste the court's time.
Arguing that seven remaining, non-settling defendants have no standing to object, the New York attorney general urged the court to ignore their request to hold off on granting preliminary approval to the indirect purchaser plaintiffs' settlements with Samsung Group and Winbond Electronics Corp.
In its long-running antitrust litigation against Mylan Laboratories over two of the generic drug maker's anti-anxiety drugs, Blue Cross Blue Shield of Massachusetts has renewed its effort to push the court to triple damages against Mylan and two drug ingredient supplier defendants, citing details from a separate case.
The Australian competition watchdog on Friday said it has slapped packaging company Visy Holdings Ltd. with a record-setting $33 million penalty for creating a cardboard box cartel, confirming speculation that began swirling last month.
U.S. enforcement agencies should rely more heavily on private litigation to complement their efforts, says Robins Kaplan's K. Craig Wildfang in our series of chats with high-profile antitrust lawyers.
A coalition of advocacy groups has asked the U.S. Federal Communications Commission to take action against Internet provider Comcast for allegedly restricting users' access to file-sharing networks such as BitTorrent and Gnutella.
The California attorney general has lambasted a judgment-sharing agreement between dynamic random access memory manufacturers, calling it an attempt to delay any settlement of the ongoing antitrust multidistrict litigation case.
As the first wave of motions to dismiss citing the Supreme Court's ruling in Bell Atlantic v. Twombly begins to crest, courts and lawyers are still figuring out how to apply the decision. Some lawyers say this process is normal, but others are complaining about inconsistent rulings and calling on the Supreme Court to clarify the issues raised by the May opinion.
Plaintiffs class action firm Cohen, Milstein, Hausfeld & Toll PLLC has expanded significantly, adding two new offices and several new partners in the past six months to enhance the firm’s abilities and talent particularly in the securities and antitrust areas.
The five major makers of artificial joints revealed that they have paid more than $200 million so far this year to doctors and hospitals as part of an agreement with the U.S. Department of Justice.
A government panel established to review Canada's competition laws has drawn up a strikingly broad agenda in its quest to update old rules and maximize the country's competitive position.
Law firm Irell & Manella must go up against a $150 million malpractice suit filed by cable operator Charter Communications for allegedly bungling a 1999 cable TV acquisition.
New York Attorney General Andrew M. Cuomo has slapped First American Corp. with a lawsuit for allegedly colluding with Washington Mutual Inc. to inflate the appraisal value of homes.
South Korea’s antitrust regulator has slapped 10 pharmaceutical companies with a $22.2 million fine after finding they provided kickbacks to hospitals and wholesalers.
The indirect purchasers in the multidistrict litigation against dynamic random access memory manufacturers have accused the defendants of essentially trying to ban any indirect purchaser claims in cases involving incorporated products.
Of the $2 billion the U.S. Department of Justice recovered for fraud against the government in fiscal year 2007, more than $1.5 billion came from health care companies, many of which shelled out huge sums to settle kickback and price inflation claims.